athenahealth

Piper Jaffray is out with its report today on athenahealth (NASDAQ: ATHN), raising its price target from $46 to $49. In a note to clients, Piper Jaffray writes, "We are connecting the dots on two independent datapoints to add context to ATHN's growth in the Enterprise pipeline. Our last note...

Piper Jaffray has raised the price target on athenahealth, Inc. (NASDAQ: ATHN) from $46 to $49 and maintains its Overweight rating.

Wells Fargo is upgrading athenahealth, Inc. (NASDAQ: ATHN) to Outperform from Market Perform. Athenahealth closed Monday at $46.13.

Goldman Sachs has published a research report on athenahealth, Inc. (NASDAQ: ATHN) following the company's reporting of 3Q earnings results. In the report, Goldman Sachs writes "athenahealth delivered solid 3Q results; driving cost improvements (notably cost of sales and G&A) while tracking...

Athenahealth, Inc. (NASDAQ: ATHN) is coming back strong after a challenging first half of the year, Piper Jaffray reports, saying that third-quarter results beat expectations across the board. “We believe ATHN can continue on its growth trajectory of 30%+ revenue growth and 40%+ EPS growth for the...

Piper Jaffray has published a Health Care Services: Information Technology report with key takeaways which are as follows: "Sharp [Healthcare] is one of about a dozen hospitals that have both Cerner and Allscripts. Getting the two vendors to cooperate has been challenging at times. At the root of...